| 2022-01 |
RamAp is an efflux pump regulator carried by an IncHI2 plasmid |
Antimicrobial Agents and Chemotherapy. 2022 Jan 18;66(1):Article number e01152-21. |
 |
| 2020-02 |
Ramucirumab (RAM) or merestinib (MER) or placebo (PL) plus gemcitabine (GEM) and cisplatin (CIS) as first-line treatment for advanced or metastatic biliary tract cancer (BTC): A randomized, double-blind, phase II study |
Journal of Clinical Oncology. 2020 Feb;38(4):Meeting Abstract 477. |
|
| 2013-11-06 |
Ran GTPase-activating protein 1 is a therapeutic target in diffuse large B-cell lymphoma |
PLoS ONE. 2013 Nov 6;8(11):Article number e79863. |
|
| 2006-01 |
Random walk, sequential analysis and related topics: A festschrift in honor of Yuan-Shih Chow. |
Random walk, sequential analysis and related topics: A festschrift in honor of Yuan-Shih Chow. |
|
| 2013-01 |
Randomised clinical trial: Comparison of two everolimus dosing schedules in patients with advanced hepatocellular carcinoma |
Alimentary Pharmacology and Therapeutics. 2013 Jan;37(1):62-73. |
|
| 2019-10 |
Randomised phase 3 study of regorafenib in refractory advanced gastro-oesophageal cancer (AGOC) - Integrate II |
Annals of Oncology. 2019 Oct;30(Suppl. 6):137. |
|
| 2010-09 |
A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients |
British Journal of Cancer. 2010 Sep;103(7):954-960. |
|
| 2004-02-26 |
A randomised phase II study of weekly paclitaxel or vinorelbine in combination with cisplatin against inoperable non-small-cell lung cancer previously untreated |
British Journal of Cancer. 2004 Feb;90(2):359-365. |
|
| 2007-08 |
A randomised placebo-controlled trial of a traditional chinese herbal formula in the treatment of primary dysmenorrhoea |
PLoS ONE. 2007 Aug;2(8):Article number e719. |
|
| 2004-03 |
Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer |
British Journal of Surgery. 2004 Mar;91(3):283-287. |
|
| 2024-11-15 |
A randomized controlled trial evaluated the efficacy and safety of apixaban for prevention of recurrent thrombosis after thrombectomy of hemodialysis vascular access |
Kidney International. 2024 Nov 15;Article in Press. |
|
| 2019-03 |
Randomized double-blind, placebo-controlled trial evaluating oral glutamine on radiation-induced oral mucositis and dermatitis in head and neck cancer patients |
American Journal of Clinical Nutrition. 2019 Mar;109(3):606-614. |
|
| 2014-05 |
Randomized open-label phase 2 study of MM-111 and paclitaxel (PTX) with trastuzumab (TRAS) in patients with HER2-expressing carcinomas of the distal esophagus, gastroesophageal (GE) junction, and stomach who have failed front-line metastatic or locally ad |
Journal of Clinical Oncology. 2014 May;32(15, Suppl.):TPS4148. |
|
| 2007-06 |
A randomized phase II study of docetaxel or vinorelbine in combination with cisplatin against inoperable, chemo-naive non-small-cell lung cancer in Taiwan |
Lung Cancer. 2007 Jun;56(3):363-369. |
|
| 2013-06-21 |
A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma |
Annals of Oncology. 2013 Jun 21;24(6):1567-1573. |
|
| 2011-02 |
Randomized phase II study of PEP02, irinotecan, or docetaxel as a second-line therapy in gastric or gastroesophageal junction adenocarcinoma |
Journal of Clinical Oncology. 2011 Feb;29(Suppl. 4 ):Abstract Number 6 |
|
| 2005-03 |
A randomized phase II study of vinorelbine plus gemcitabine with/without cisplatin against inoperable non-small-cell lung cancer previously untreated |
Lung Cancer. 2005 Mar;47(3):373-380. |
|
| 2012-05-20 |
Randomized phase II trial of TACE plus everolimus as first-line therapy in localized unresectable hepatocellular carcinoma (HCC): The TRACER trial |
Journal of Clinical Oncology. 2012 May 20;30(15 Suppl.):Abstract number TPS4149. |
|
| 2003-02 |
A randomized trial comparing intravesical instillations of mitoxantrone and doxorubicin in patients with superficial bladder cancer |
Chang Gung Medical Journal. 2003 Feb;26(2):91-97. |
|
| 2006-04 |
A randomized trial of different docetaxel schedules in non-small cell lung cancer patients who failed previous platinum-based chemotherapy |
Chest. 2006 Apr;129(4):1031-1038. |
|
| 2010-04 |
A Randomized, Double-blind, Parallel, Comparative Study to Evaluate the Efficacy and Safety of Ramosetron plus Dexamethasone Injection for the Prevention of Acute Chemotherapy-induced Nausea and Vomiting |
Japanese Journal of Clinical Oncology. 2010 Apr;40(4):294-301. |
|
| 2010-06 |
Randomized, phase 1 study of everolimus in patients with advanced hepatocellular carcinoma |
Annals of Oncology. 2010 Jun;21(Suppl. 6):27. |
|
| 2009-05-20 |
Randomized, phase I, and pharmacokinetic (PK) study of RAD001, an mTOR inhibitor, in patients (pts) with advanced hepatocellular carcinoma (HCC) |
Journal of Clinical Oncology. 2009 May 20;27(15s):Abstract number 4587. |
|
| 2018-10 |
Randomized, phase III trial comparing adjuvant gemcitabine (Gem) versus Gem plus chemoradiation (CCRT) in curatively resected pancreatic ductal adenocarcinoma (PDAC): A Taiwan cooperative oncology group study |
Annals of Oncology. 2018 Oct;29(Suppl. 8):Meeting Abstract 626PD. |
|
| 2015-05 |
Randomized, phase III trial of adjuvant adeforvir vs. therapeutic lamivudine in post-operative BCLC stage 0 or A HBV-related HCC: The Taiwan Cooperative Oncology Group T1206 study |
Journal of Clinical Oncology. 2015 May;33(15, Suppl.):4101. |
|
